These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17666364)

  • 21. Immunogenetics of chronic lymphocytic leukemia.
    Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
    Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
    Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
    Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients.
    Finn WG; Kay NE; Kroft SH; Church S; Peterson LC
    Am J Hematol; 1998 Nov; 59(3):223-9. PubMed ID: 9798660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
    Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
    Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
    Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
    Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic lymphocytic leukemia in a young population.
    Alshemmari SH; Hamdah A; Pandita R; Kunhikrishnan A
    Leuk Res; 2021 Nov; 110():106668. PubMed ID: 34492597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
    Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
    J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation.
    Qiu HX; Xu W; Cao XS; Zhou M; Shen YF; Xu YL; Sun XM; Liu Q; Wang R; Qiu HR; Wang JS; Li JY
    Leuk Lymphoma; 2008 Oct; 49(10):1887-92. PubMed ID: 18949612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
    Haslinger C; Schweifer N; Stilgenbauer S; Döhner H; Lichter P; Kraut N; Stratowa C; Abseher R
    J Clin Oncol; 2004 Oct; 22(19):3937-49. PubMed ID: 15459216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
    Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE; Dewald GW
    J Clin Oncol; 2006 Oct; 24(28):4634-41. PubMed ID: 17008705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Lymphocytic Leukemia With Two B-Cell Populations of Discordant Light Chain Restrictions in Individual Patients: Parallel Development of Biclonal B-Cell Neoplasms or Clonal Evolution With Isotype Switch?
    Zhao Y; Siddiqi I; Wildes TJ; McCracken J; Deak K; Rehder C; Wang E
    Am J Clin Pathol; 2023 Apr; 159(4):337-351. PubMed ID: 36749322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
    Xu W; Wang YH; Fan L; Fang C; Zhu DX; Wang DM; Qiao C; Wu YJ; Li JY
    Leuk Res; 2011 Aug; 35(8):1060-5. PubMed ID: 21208658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence.
    Yoon JH; Kim Y; Yahng SA; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Lim J; Kim Y; Han K; Kim M; Cho SG
    Hematol Oncol; 2014 Dec; 32(4):169-77. PubMed ID: 24123081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic prognostic markers.
    Stilgenbauer S; Döhner H
    Curr Top Microbiol Immunol; 2005; 294():147-64. PubMed ID: 16323431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.